Literature DB >> 10481058

Proteolytic cleavage of beta-catenin by caspases: an in vitro analysis.

M Van de Craen1, G Berx, I Van den Brande, W Fiers, W Declercq, P Vandenabeele.   

Abstract

Cleavage of structural proteins by caspases has been associated with the severe morphological changes occurring during the apoptotic process. One of the proteins regulating the connection of the actin filament with cadherins in a cell-cell adhesion complex is beta-catenin. During apoptosis, both an N-terminal and a small C-terminal part are removed from beta-catenin. Removal of the N-terminal part may result in a disconnection of the actin filament from a cadherin cell-cell adhesion complex. We demonstrate that caspase-8, -3 and -6 directly proteolyse beta-catenin in vitro. However, the beta-catenin cleavage products generated by caspase-8 were different from those generated by caspase-3 or caspase-6. Caspase-1, -2, -4/11 and -7 did not or only very inefficiently cleave beta-catenin. These data suggest that activation of procaspase-3, -6 or -8 by different stimuli in the cell might result in a differential proteolysis of beta-catenin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10481058     DOI: 10.1016/s0014-5793(99)01153-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Transcription factor AP-2alpha is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells.

Authors:  O Nyormoi; Z Wang; D Doan; M Ruiz; D McConkey; M Bar-Eli
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  Wnt11 promotes cardiomyocyte development by caspase-mediated suppression of canonical Wnt signals.

Authors:  Mohammad Abdul-Ghani; Daniel Dufort; Rebecca Stiles; Yves De Repentigny; Rashmi Kothary; Lynn A Megeney
Journal:  Mol Cell Biol       Date:  2010-11-01       Impact factor: 4.272

3.  Cyclosporine A--protection against microvascular hyperpermeability is calcineurin independent.

Authors:  Ed W Childs; Binu Tharakan; Suliat Nurudeen; Thomas L Delmas; Joseph Hellman; Tasheika Christie; Felicia A Hunter; W Roy Smythe
Journal:  Am J Surg       Date:  2010-04       Impact factor: 2.565

4.  Cleavage of MAGI-1, a tight junction PDZ protein, by caspases is an important step for cell-cell detachment in apoptosis.

Authors:  Uros Gregorc; Saska Ivanova; Miranda Thomas; Ernesto Guccione; Britt Glaunsinger; Ron Javier; Vito Turk; Lawrence Banks; Boris Turk
Journal:  Apoptosis       Date:  2007-02       Impact factor: 4.677

5.  Down-regulation of beta-catenin by activated p53.

Authors:  E Sadot; B Geiger; M Oren; A Ben-Ze'ev
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

6.  Hydrogen sulfide-releasing aspirin inhibits the growth of leukemic Jurkat cells and modulates β-catenin expression.

Authors:  Mitali Chattopadhyay; Niharika Nath; Ravinder Kodela; Tomasz Sobocki; Shalaka Metkar; Zong Yuan Gan; Khosrow Kashfi
Journal:  Leuk Res       Date:  2013-07-26       Impact factor: 3.156

7.  The loss of tuberin promotes cell invasion through the ß-catenin pathway.

Authors:  Elizabeth A Barnes; Heidi L Kenerson; Baldwin C Mak; Raymond S Yeung
Journal:  Am J Respir Cell Mol Biol       Date:  2009-12-30       Impact factor: 6.914

8.  Proteolysis of Ambra1 during apoptosis has a role in the inhibition of the autophagic pro-survival response.

Authors:  V Pagliarini; E Wirawan; A Romagnoli; F Ciccosanti; G Lisi; S Lippens; F Cecconi; G M Fimia; P Vandenabeele; M Corazzari; M Piacentini
Journal:  Cell Death Differ       Date:  2012-03-23       Impact factor: 15.828

9.  17beta-estradiol mediated protection against vascular leak after hemorrhagic shock: role of estrogen receptors and apoptotic signaling.

Authors:  Ed W Childs; Binu Tharakan; Felicia A Hunter; W Roy Smythe
Journal:  Shock       Date:  2010-09       Impact factor: 3.454

10.  Non-canonical β-catenin degradation mediates reactive oxygen species-induced epidermal cell death.

Authors:  E Omori; K Matsumoto; J Ninomiya-Tsuji
Journal:  Oncogene       Date:  2011-03-07       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.